301257.SZ
SMO ClinPlus Co., Ltd.
SZSE · M 科研服务 · CN
CNY 45.22
−6.80%Year over year
Reported trailing growth
- Revenue
- +8.1%
- EBITDA
- —
- EBIT
- +29.1%
- EPS
- +9.8%
- Free cash flow
- +191.2%
- Operating cash flow
- +240.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +12.8%
- EBITDA
- +16.7%
- EBIT
- +16.5%
- Net income
- +14.8%
- EPS
- +0.7%
- Free cash flow
- -5.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026